Toprol XL overdosage: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Metoprolol succinate#Overdosage]]
{{Metoprolol}}
{{CMG}}
 
==Overdosage==
 
<u>'''Signs and Symptoms'''</u> - Overdosage of TOPROL-XL may lead to severe bradycardia, hypotension, and cardiogenic shock. Clinical presentation can also include: atrioventricular block, heart failure, bronchospasm, hypoxia, impairment of consciousness/coma, nausea and vomiting.
 
<u>'''Treatment'''</u> – Consider treating the patient with intensive care. Patients with myocardial infarction or heart failure may be prone to significant hemodynamic instability. Seek consultation with a regional poison control center and a medical toxicologist as needed. Beta-blocker overdose may result in significant resistance to resuscitation with adrenergic agents, including beta-agonists. On the basis of the pharmacologic actions of metoprolol, employ the following measures.
 
There is very limited experience with the use of hemodialysis to remove metoprolol, however metoprolol is not highly protein bound.
 
<u>'''Bradycardia'''</u>: Administer intravenous atropine; repeat to effect. If the response is inadequate, consider intravenous isoproterenol or other positive chronotropic agents. Evaluate the need for transvenous pacemaker insertion.
 
<u>'''Hypotension'''</u>: Treat underlying bradycardia. Consider intravenous vasopressor infusion, such as dopamine or norepinephrine.
 
<u>'''Bronchospasm'''</u>: Administer a beta2-agonist, including albuterol inhalation, or an oral theophylline derivative.
 
<u>'''Cardiac Failure'''</u>: Administer diuretics or digoxin for congestive heart failure. For cardiogenic shock, consider IV dobutamine, isoproterenol, or glucagon.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01038198-b4f0-41f3-9a9c-5c84e5a0d3b9 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
 
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Beta blockers]]

Latest revision as of 03:41, 22 July 2014